Psoriasis

The AJMC® Psoriasis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin disease, which tends to go through cycles where it flares and goes into remission.

Latest News

Person reading on phone | Image credit: Farknot Architect - stock.adobe.com
Opportunities, Challenges in Digital Media and Psoriasis

September 10th 2025

A study explores how people with psoriasis use digital media, revealing benefits, pitfalls, and gaps in physician-patient communication.

Doctor examines patient with psoriasis rash | ARTFULLY-79 - stock.adobe.com
Real-World Data Show 12-Month Drug Survival Rates Among Anti-TNF Biosimilars in Psoriasis, PsA

September 8th 2025

Adalimumab | Image credit: luchschenF - stock.adobe.com
Infection Risk Higher in HS Compared With Psoriasis With Adalimumab

September 2nd 2025

Psoriatic arthritis | Image credit: Oporty786 - stock.adobe.com
The Totality of Evidence of Ustekinumab Biosimilar SB17

September 1st 2025

Psoriasis treatment concept | Sviatlana - stock.adobe.com
Beyond the Surface: How New Therapies, Patient-Centered Care Are Changing Psoriasis Outcomes

August 19th 2025

A Personalized Approach to Disease Management in Psoriasis

A panel of experts discuss their personalized approaches to treating patients with psoriasis and comorbidities such as metabolic syndrome.

Ryan Haumschild, PharmD, MS, MBA, Bhavesh Shah, PharmD, Mark Lebwohl, MD, and Robert Groves, MD.
Continuing Medical Education
View All
September 14th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
September 14th 2025

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape for Managed Care Professionals

August 19, 2025 | 1:00 PM & 8:00 PM ET
September 14th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

image of psoriasis
April 25th 2023

Cost Burden of GPP Much Higher Than Psoriasis Vulgaris, Study Finds

Jared Kaltwasser
Ten-year mean costs associated with psoriasis-related health care visits were 10 times higher for patients with generalized pustular psoriasis (GPP).
Itching in a woman: © RFBSIP - stock.adobe.com
April 14th 2023

Biologics May Prevent PsA in Patients With Psoriasis

Gianna Melillo
Because biologics are used to treat both conditions, researchers hypothesized they may be helpful to prevent psoriatic arthritis (PsA).
Tildrakizumab monoclonal antibody drug. Used in treatment of psoriasis. Targets interleukin-23. Generic name and stylized antibody representation: © molekuul.be- stock.adobe.com
April 12th 2023

Trial Results Show Tildrakizumab Is Safe, Effective for Psoriasis Across Ages

Gianna Melillo
This analysis pooled data from the reSURFACE 1 and reSURFACE 2 trials of tildrakizumab use among patients with moderate to severe plaque psoriasis.
image of dermatologist visit
March 24th 2023

Examining Health Care Disparities in Psoriasis and Other Skin Diseases

Pearl Steinzor
Minority patients with skin diseases such as psoriasis often experience racial and ethnic barriers to care, a recent review found.
Image of an online survey: Tierney - stock.adobe.com
March 21st 2023

Race, Ethnicity May Not Affect Biologic Prescribing Patterns for Psoriasis

Jared Kaltwasser
Dermatologists recommended biologics at similar rates in scenarios describing Black, Hispanic, and White patients with moderate to severe psoriasis.
image of hands with psoriatic arthritis
March 18th 2023

Polypharmacy Is Significantly Higher in Patients With Psoriatic Arthritis

Lana Pine
Polypharmacy was significantly higher in patients with psoriatic arthritis when compared with controls, according to a new study.
Image of a mobile health app: adam - stock.adobe.com
March 14th 2023

Accurate Remote Assessment of Psoriasis Possible From Patient Photographs, Questionnaire Responses, Study Finds

Jared Kaltwasser
In this new analysis, investigators found significant agreement between in-person and remote assessments.
Final Thoughts on Psoriasis Across Skin Types
February 28th 2023

Final Thoughts on Psoriasis Across Skin Types

A panel of experts provide their final thoughts on treating psoriasis across all skin phototypes.
Health Equity Across All Skin Phototypes
February 28th 2023

Health Equity Across All Skin Phototypes

A panel of experts provide their final thoughts on treating psoriasis across all skin phototypes.
Incentivizing Patient Use of Digital Health Tools
February 28th 2023

Incentivizing Patient Use of Digital Health Tools

Maria Lopes, MD, MS, and Amy McMichael, MD, discuss how payers can incentivize patients’ use of digital health tools to monitor the success or failure of treatment.
Psorcast: A Digital Health Tool for Patients
February 21st 2023

Psorcast: A Digital Health Tool for Patients

Amy McMichael, MD, provides an overview of the Psorcast app and how it can benefit treatment adherence for patients.
Addressing Disparities in Care for Psoriasis
February 21st 2023

Addressing Disparities in Care for Psoriasis

Bruce Sherman, MD, FCCP, FACOEM, and Maria Lopes, MD, MS, discuss how organizations can address disparities in care for psoriasis.
Challenges Across Skin Phenotypes
February 14th 2023

Challenges Across Skin Phenotypes

Maria Lopes, MD, MS, reviews some challenges surrounding access to care, patient education, and financial burdens associated with psoriasis across skin phototypes.
Ensuring Equal Face-to-Face Provider-Interaction Time Among Patients
February 14th 2023

Ensuring Equal Face-to-Face Provider-Interaction Time Among Patients

Amy McMichael, MD, discusses ways to ensure patients of all races and ethnicities are experiencing the same level of quality face-to-face interactions with their providers.
Site Logo
February 11th 2023

Migraine More Common in Patients With Psoriasis, Say Findings

Jaime Rosenberg
The subset of patients with psoriatic arthritis had the highest odds ratio of migraine.
picture of depressed person
February 10th 2023

Survey: Depression Worsened Psoriasis Symptoms, QOL During COVID-19 Lockdown

Jaime Rosenberg
Findings from the survey suggest that certain symptoms of depression could help identify patients vulnerable to both worsening psoriasis symptoms and disease-related quality of life (QoL).
Educating Providers and Improving Early Diagnosis
February 7th 2023

Educating Providers and Improving Early Diagnosis

Maria Lopes, MD, MS, reviews how to educate providers on the risks and burdens of psoriasis and how to improve early diagnosis and treatment for all skin phototypes and ethnicities.
Financial Burden on Psoriasis Patients
February 7th 2023

Financial Burden on Psoriasis Patients

Bruce Sherman, MD, FCCP, FACOEM, underlines how to support patients financially to afford therapies and maintain adherence.
Image of a lot of people
February 4th 2023

Common PsA Symptoms Negatively Impact Quality of Life

Jared Kaltwasser
A study attempted to see how symptoms affect quality of life after adjusting for confounding factors.
Image of different emotions
February 1st 2023

Prevalence of Mental Health Comorbidities in Psoriasis Probed in New Study

Jared Kaltwasser
The exact reasons for the links are not yet clear, although some evidence suggests inflammation plays a role.
Costs and Burdens of Psoriasis
January 31st 2023

Costs and Burdens of Psoriasis

Amy McMichael, MD, and Maria Lopes, MD, MS, review the major differences in quality of life, the impact on patients, and the costs and burdens associated with absenteeism or presentism.
Valuable Quality of Life Assessments in Psoriasis
January 31st 2023

Valuable Quality of Life Assessments in Psoriasis

Amy McMichael, MD, explores why psoriasis can substantially affect quality of life more severely in some ethnicities more than others.
Improving Treatment for Psoriasis Across All Skin Phenotypes
January 24th 2023

Improving Treatment for Psoriasis Across All Skin Phenotypes

Bruce Sherman, MD, FCCP, FACOEM, explores how to improve treatment for psoriasis and education surrounding diagnosing psoriasis for all skin phototypes.
Factors to Evaluate When Initiating Psoriasis Treatment
January 24th 2023

Factors to Evaluate When Initiating Psoriasis Treatment

Amy McMichael, MD, and Maria Lopes, MD, MS, review factors to evaluate when starting treatment and how to educate patients on the possible adverse events from that treatment.
Wildfire in forest.
January 22nd 2023

Wildfire Air Pollution Linked With Increased Rates of Psoriasis Clinic Visits Among Adults

Matthew Gavidia
After a delayed lag period, air pollution from a wildfire was associated with modestly increased rates of clinic visits for psoriasis among adults starting 5 weeks after the fire and peaking at 8 to 9 weeks after the fire.
Image of Air Pollution
January 17th 2023

Potential Link Found Between Spikes in Air Pollution, Outpatient Psoriasis Visits

Jared Kaltwasser
Female patients and people younger than 18 years were particularly sensitive to pollution levels, this study found.
Biologic injectable drug.
January 13th 2023

Examining Patient Preferences for Biologic Use in Psoriasis

Matthew Gavidia
Following COVID-19–related lockdown measures, preferences for the use of biologics among Japanese patients with psoriasis addressed administration route, visits, and risk of serious infections requiring hospitalization, with some differences observed between specific subgroups.
person working.
January 5th 2023

Improved Work-, Study-Related Productivity Shown With Tildrakizumab in Patients With Psoriasis

Matthew Gavidia
Abstract findings presented at the 2022 American Academy of Dermatology Annual Meeting showed that patients with moderate to severe psoriasis achieved improvement in work-/study-related productivity with tildakizumab vs placebo after only 2 doses.
patient with psoriasis flare.
January 5th 2023

Examining Modifiable Risk Factors in Psoriasis

Matthew Gavidia
Findings of a Mendelian randomization analysis showed that greater body mass index as a child and adult and incidence of smoking were associated with an increased risk of psoriasis, whereas having more education was cited as a potential protective factor against development.
People walking.
January 3rd 2023

Systemic Drug Trends Seemingly Vary by Season in Patients With Psoriasis

Matthew Gavidia
Approximately 14,280 more US patients with psoriasis were estimated to initiate a biologic in Spring than in other seasons, and over 840 more biologic users switched in Spring than in Winter.
<123456789
...
16>

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo